410 related articles for article (PubMed ID: 15204241)
1. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI.
Otterstad JE; Brosstad F
Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241
[No Abstract] [Full Text] [Related]
2. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
[TBL] [Abstract][Full Text] [Related]
3. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
Ferguson JJ; Wilson JM; Diez J
Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
[TBL] [Abstract][Full Text] [Related]
4. Unstable angina.
Natarajan M
Clin Evid; 2002 Jun; (7):214-26. PubMed ID: 12230645
[No Abstract] [Full Text] [Related]
5. Unstable angina.
Natarajan M
Clin Evid; 2002 Dec; (8):225-35. PubMed ID: 12603879
[No Abstract] [Full Text] [Related]
6. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
Rubboli A; Halperin JL
Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
[No Abstract] [Full Text] [Related]
7. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
Roldán V; Marín F
Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
[No Abstract] [Full Text] [Related]
8. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
Kandzari DE
Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
[TBL] [Abstract][Full Text] [Related]
9. Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.
Chew DP; Moliterno DJ; Herrmann HC
J Invasive Cardiol; 2002 Feb; 14 Suppl A():3A-20A. PubMed ID: 11847402
[No Abstract] [Full Text] [Related]
10. Evolving management of ST-segment elevation myocardial infarction: update on recent data.
Cannon CP
Am J Cardiol; 2006 Dec; 98(12A):10Q-21Q. PubMed ID: 17169625
[TBL] [Abstract][Full Text] [Related]
11. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ;
Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503
[TBL] [Abstract][Full Text] [Related]
12. Current antiplatelet therapies: benefits and limitations.
Angiolillo DJ; Guzman LA; Bass TA
Am Heart J; 2008 Aug; 156(2 Suppl):S3-9. PubMed ID: 18657680
[TBL] [Abstract][Full Text] [Related]
13. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
Mehta SR;
J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous coronary intervention versus thrombolysis: the definite management of st elevation myocardial infarction.
Martinez-Ojeda J; Martinez-Toro J
Bol Asoc Med P R; 2005; 97(4):308-14. PubMed ID: 16599071
[TBL] [Abstract][Full Text] [Related]
15. [Standard pharmacological therapy associated with percutaneous coronary interventions in patients with stable angina].
Karcz M; Ruzyłło W
Kardiol Pol; 2004 Nov; 61(11):480-2. PubMed ID: 15883598
[No Abstract] [Full Text] [Related]
16. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
Sauer H; Leschke M
Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
[No Abstract] [Full Text] [Related]
17. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?
Jackson G
Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219
[No Abstract] [Full Text] [Related]
18. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).
Alexander D; Mann N; Ou FS; Peterson ED; Ohman EM; Gibler WB; Roe MT
Am J Cardiol; 2008 Nov; 102(10):1335-40. PubMed ID: 18993151
[TBL] [Abstract][Full Text] [Related]
19. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Fernandez JS; Sadaniantz A
Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658
[No Abstract] [Full Text] [Related]
20. Optimal antithrombotic treatment for percutaneous coronary intervention.
Kadakia RA; Ferguson JJ
Minerva Cardioangiol; 2005 Feb; 53(1):15-42. PubMed ID: 15788977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]